Assessment of Response to a Third Dose of the SARS-CoV-2 BNT162b2 mRNA Vaccine in Patients with Solid Tumors Undergoing Active Treatment

Yakir Rottenberg; Albert Grinshpun; Iddo Z. Ben-Dov; Esther Oiknine Djian; Dana G. Wolf; Luna Kadouri

doi:10.1001/jamaoncol.2021.6764

Assessment of Response to a Third Dose of the SARS-CoV-2 BNT162b2 mRNA Vaccine in Patients with Solid Tumors Undergoing Active Treatment

Yakir Rottenberg, Albert Grinshpun, Iddo Z. Ben-Dov, Esther Oiknine Djian, Dana G. Wolf, Luna Kadouri

Institute for Medical Research Israel-Canada (IMRIC)

The Hebrew University of Jerusalem

Research output: Contribution to journal › Letter › peer-review

Abstract

This cohort study evaluates the short-term humoral response to a third dose of the SARS-CoV-2 BNT162b2 vaccine in patients undergoing acute systemic therapy for solid tumors.

Original language	English
Pages (from-to)	300-301
Number of pages	2
Journal	JAMA Oncology
Volume	8
Issue number	2
DOIs	https://doi.org/10.1001/jamaoncol.2021.6764
State	Published - Feb 2022

All Science Journal Classification (ASJC) codes

Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1001/jamaoncol.2021.6764

Cite this

@article{f22845b594714199bb9eeca971a158b1,

title = "Assessment of Response to a Third Dose of the SARS-CoV-2 BNT162b2 mRNA Vaccine in Patients with Solid Tumors Undergoing Active Treatment",

abstract = "This cohort study evaluates the short-term humoral response to a third dose of the SARS-CoV-2 BNT162b2 vaccine in patients undergoing acute systemic therapy for solid tumors.",

author = "Yakir Rottenberg and Albert Grinshpun and Ben-Dov, {Iddo Z.} and {Oiknine Djian}, Esther and Wolf, {Dana G.} and Luna Kadouri",

year = "2022",

month = feb,

doi = "10.1001/jamaoncol.2021.6764",

language = "الإنجليزيّة",

volume = "8",

pages = "300--301",

journal = "JAMA Oncology",

issn = "2374-2437",

publisher = "American Medical Association",

number = "2",

}

TY - JOUR

T1 - Assessment of Response to a Third Dose of the SARS-CoV-2 BNT162b2 mRNA Vaccine in Patients with Solid Tumors Undergoing Active Treatment

AU - Rottenberg, Yakir

AU - Grinshpun, Albert

AU - Ben-Dov, Iddo Z.

AU - Oiknine Djian, Esther

AU - Wolf, Dana G.

AU - Kadouri, Luna

PY - 2022/2

Y1 - 2022/2

N2 - This cohort study evaluates the short-term humoral response to a third dose of the SARS-CoV-2 BNT162b2 vaccine in patients undergoing acute systemic therapy for solid tumors.

AB - This cohort study evaluates the short-term humoral response to a third dose of the SARS-CoV-2 BNT162b2 vaccine in patients undergoing acute systemic therapy for solid tumors.

UR - http://www.scopus.com/inward/record.url?scp=85120058939&partnerID=8YFLogxK

U2 - 10.1001/jamaoncol.2021.6764

DO - 10.1001/jamaoncol.2021.6764

M3 - رسالة

C2 - 34812840

SN - 2374-2437

VL - 8

SP - 300

EP - 301

JO - JAMA Oncology

JF - JAMA Oncology

IS - 2

ER -

Assessment of Response to a Third Dose of the SARS-CoV-2 BNT162b2 mRNA Vaccine in Patients with Solid Tumors Undergoing Active Treatment

Abstract

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this